References 01 - 49

1) A. Luger, B. Watschinger, P. Deuster, T. Svoboda, M. Clodi, G.P. Chrousus: Plasma Growth Hormon and Prolactin responses to graded levels of acute exercise and lactate infusion. Neuroendocrinology 1992;56:112-117

2) T. Svoboda, A. Wagner, P. Speiser, M. Clodi, A. Luger: Epidermal Growth Factor plasma concentrations in healthy control persons, acute and chronic stress and during pregnancy. Horm Metab Res. 1992;24:582-584.

3) M. Clodi, T. Svoboda, H. Kotzmann, R. Deyssig, W. Woloszczuk, CC. Zielinski, A. Luger: Effect of elevated serum prolactin concentrations on cytokine production and natural killer cell activity. Neuroendocrinology 1992;56:775-779.

4) H. Gisslinger, T. Svoboda, M. Clodi, B. Gilly, H. Ludwig, R. Hawelec, A. Luger: Interferon alpha stimulates the Hypothalamic-Pituitary-Adrenal-Axis in vivo and in vitro. Neuroendocrinology 1993;57:489-495.

5) B. Ludvik, M. Clodi, A. Kautzky-Willer, M. Capek, E. Hartter, G. Pacini, R. Prager: Effects of dexamethasone on insulin sensivity, islet amyloid polypeptide and insulin secretion in humans. Diabetolgia 1993;36:84-87.

6) T. Svoboda, H. Kotzmann, M. Clodi, P. Bernecker, G. Geyer, A. Luger: The non ergot D2-dopamine agonist CV 205-502 decreases growth hormone concentrations in acromegalic patients. Endocr Res 1994;20:59-63.

7) W. Pirker, T. Brücke, M. Riedl, M. Clodi, A. Luger, S. Asenbaum, I. Podrecka and L. Deecke: Iodine-123-IBZM-SPECT:studies in 15 patients with pituitary tumors. J Neural Transm [GenSect] 1994;97:235-244.

8) A. Kautzky-Willer, K. Thomaseth, G. Pacini, M. Clodi, B. Ludvik, C. Streli, W. Waldhäusl, R. Prager: Role of islet amyloid polypeptide secretion in insulin- resistant humans. Diabetologia 1994;37:188-194.

9) B. Ludvik, M. Clodi, A. Kautzky-Willer, M. Schuller, H. Graf, E. Hartter, G. Pacini and R. Prager: Increased levels of circulating Islet Amyloid Polypeptide in patients with chronic renal failure have no effect on insulin scretion. J. Clin. Invest. 1994;94:2045-2050.

10) P. Fürnsinn, H. Leuvenink, M. Roden, P. Nowotny, B. Schneider, M. Rohac, T. Pieber, M. Clodi, and W. Waldhäusl: Islet amyloid polypeptide inhibits insulin secretion in conscious rats. Am. J. Physiol. 1994;267(Endocrinol.Metab.30):E300-E305

11) H. Kotzmann, T. Svoboda, P. Bernecker, M. Clodi, W. Woloszczuk, B. Niederle, W. Waldhäusl, A. Luger: Dinatriumpamidronat (APD) als Therapie der Hypercalciämie bei primärem Hyperparathyreoidismus. Wien Klin Wochenschr 1994;106:422-425

12) H. Kotzmann, M. Köller, S. Czernin, M. Clodi, T. Svoboda, M. Riedl, G. Boltz- Nitulescu, CC. Zielinski, A. Luger: Effect of elevated Growth hormone concentrations on the phenotype and functions of human Lymphocytes and natural killer cells. Neuroendocrinology 1994;60:618-625

13) F. Längle, T. Soliman, N. Neuhold, G. Widhalm, B. Niederle, S. Roka, K. Kaserer, W. Blauensteiner, K. Dam, M. Clodi, J. Flores, A. Loidl, B. Schwarzmüller, E. Huber, G. Jahl, K. Wamprechtsberger, R. Roka: CD 15 (LeuM1) immunoreactivity: prognostic factor for sporadic and hereditary medullary thyroid cancer? World-J-Surg 1994;18:583-587.

14) H. Kotzmann, M. Linkesch, B. Ludvik, M. Clodi, A. Luger, G. Schernthaner, R. Prager, R. Klauser. Effect of danazol induced chronic hyperglucagonemia on glucose tolerance and turnover. Eur J Clin Invest 1995;25:942-947

15) M. Clodi, H. Kotzmann, G. Fischer, M. Riedl, O. Presslich, C. Schneider, K. Diamant, A. Luger. Life threatening hemolysis in a 27 year old drug addict. European Psychiatry 1995;10: 416 (letter)

16) H. Kotzmann, M. Riedl, M. Clodi, U. Barnas, A. Kaider, P. Höcker, A. Luger. The influence of growth hormone substitution therapy on erythroid and myeloid progenitor cells and on peripheral blood cells in adult patients with growth hormone deficiency. Eur J Clin Invest 1996;12:1175-1181

17) A. Kautzky-Willer, K. Thomaseth, M. Clodi, B. Ludvik, W. Waldhäusl, R. Prager, G. Pacini: B-cell activity and hepatic insulin extraction following dexamethasone administration in healthy subjects. Metabolism 1996;45:486-491

18) U. Hoffmann, C. Kurek, K. Kostner, C. Scholten, M. Clodi, I. Lang, T. Stefenelli: Atypical elevation of creatinin phosphokinase and isoenzymes (CK-MB) levels in a patient with mitral valve disease. Europ. Heart J. 1996;17:1764-5 (letter)

19) M. Clodi, H. Kotzmann, M. Riedl, A. Schmidt, U. Barnas, F. Mühlbacher, G. Mustafa, W. Hörl, W. Waldhäusl, G. Mayer and A. Luger: The long acting dopamine agonist bromocriptine mesylate as additive immunsuppressive drug after kidney transplantation. Nephrology Dialysis Transplantation 1997; Apr,V12N4:748-752

20) M. Köller, H. Kotzmann, M. Clodi, M. Riedl, A. Luger. Effect of elevated serum prolactin concentration on the immuno-phenotype of human lymphocytes, mitogen induced proliferation and phagocytic activity of polymorphonuclear cells. Eur J Clin Invest 1997;Aug 27(8):662-666

21) K. Thomaseth, G. Pacini, M. Clodi, A. Kautzky-Willer, J.J. Nolan, R. Prager, J.M. Olefsky, B. Ludvik. Amylin release during oral glukose tolerance test. Diabetic Medicine 1997;14:S29-S34

22) H. Kotzmann, C. Abela, J. Heindl, M. Clodi, M. Riedl, U. Barnas, K. Geissler, B. Niederle, W. Waldhäusl, A. Luger. Effect of successful parathyroidectomy on hematopoietic progenitor cells and parameters of red blood cells in patients with primary hyperparathyroidism. Horm Metab Res 1997; V29,N8:387-392

23) M. Clodi, R. Oberbauer, W. Waldhäusl, G. Maurer, G. Kostner, K. Kostner: Urinaryexcretion of apo (a) fragments in NIDDM patients.Diabetologia 1997; 40:1455-1460

24) H. Kotzmann, M. Riedl, P. Bernecker, M. Clodi, F. Kainberger, A. Kaider,W. Woloszczuk, A. Luger: Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency.Calcified Tissue Int 1998; Jan, V62 N1:40-46

25) M. Clodi, M. Riedl, S. Schmaldienst, A. Vichytil, H. Kotzmann, A. Kaider, G. Mayer, C. Bieglmayer, W. Waldhäusl, A. Luger: Adrenal function in patients with chronic renal failure.Am J Kidney Diseases 1998 Jul, V32 N1:52-55.

26) M. Clodi, K. Thomaseth, G. Pacini, K. Hermann, A. Kautzky-Willer, W. Waldhäusl, R. Prager, B. Ludvik: Distribution and kinetics of amylin in humans.Am J Physiol-Endocrinol and Metab 1998; May, V37 N5:E903-E908.

27) K. Kostner, M. Clodi, B. Watschinger, W. Hörl, K. Derfler, K. Huber: Decreased uirnary apo(a) excretion in patients with impaired renal function. Eur J Clin Invest. 1998; Jun, 28(6): 447-452.

28) H. Kotzmann, M. Koller, C. Abela, M. Clodi, M. Riedl, W. Graninger, B. Niederle,A. Luger: Effects of parathyroid hormone and serum calcium on the phenotypeand function of mononuclear cells in patients with primary hyperparathyroidism.Eur J Clin Invest 1998; May, 28(5): 353-358

29) M. Clodi, J. Klarlund, P. Vollenweider, N. Nakashima, M. Czech, J. Olefsky: Effectsof GRP1 (General Receptor for Phosphoinositides 1) on Insulin and IGF I induced GLUT 4 Translocation, Membrane Ruffling and DNA Synthesis.Endocrinology 1998; 139:4984-490.

30) P. Vollenweider, M. Clodi, S. Martin, T. Imamura, W, Kavanaugh, J. M. Olefsky: An SH2 containing 5'Inositolphosphatase (SHIP) inhibits insulin-induced GLUT4 Translocation and Growth factors induced Actin Filament rearrangement.Molecular and Cellular Biology, 1999, V19 N2:1081-1091.

31) M. Clodi, R. Oberbauer R, Bodlaj G, Hofmann J, Maurer G, Kostner K.: Urinary excretion of apolipoprotein(a) fragments in type 1 diabetes mellitus patients. Metabolism. 1999 Mar; 48(3):369-72.

32)T. Imamura, P. Vollenweider, K. Egawa, M. Clodi, K. Ishibashi, N. Nakashima, S. Ugi, J. Adams, J. Brown, J. Olefsky: G Alpha-q/11 protein plays a key role in insulin-induced glucose transport in 3T3-L1 adipocytenMolecular and Cellular Biology, 1999, 10 V19:6765-6774.

33) Blank D, Riedl M, Reitner A, Schnack C, Schernthaner G, Clodi M, Frisch H, Luger A: Growth hormone replacement therapy is not associated with retinal changes. J Clin Endocrinol Metab 2000 Feb;85(2):634-6

34) Kostner K, Clodi M, Bodlaj G, Hoffmann U, Hermann K, Maurer G, Pacher R, Horl WH: Urinary apo(a) excretion is not altered by changes in glomerular filtration rate and renal plasma flow in healthy males. Wien Klin Wochenschr 2000 Feb 11;112(3):121-5

35) Roden M, Ludwig C, Nowotny P, Schneider B, Clodi M, Vierhapper H, Roden A,Waldhausl W: Relative hypoleptinemia in patients with type 1 and type 2 diabetes mellitus. Int J Obes Relat Metab Disord 2000 Aug;24(8):976-81

36) M. Riedl, B. Ludvik, G. Pacini, M. Clodi, H. Kotzmann, O. Wagner, A. Kautzky-Willer, R. Prager and A. Luger: The increased insulin sensitivity in growth hormone-deficient adults is reduced by growth hormone replacement therapy Eur J Clin Invest. 2000 Sep;30(9):771-8.

37) Riedl M, M. Clodi, Kotzmann H, Hainfellner JA, Schima W, Reitner A, Czech T, Luger : Apoplexy of a pituitary macroadenoma with reversible third, fourth and sixth cranial nerve palsies following administration of hypothalamicEur J Radiol 2000 Oct;36(1):1-4

38) M. ClodiKortikosteroide im septischen SchockWien. Med. Wschr. 2002:152;555-558

39) M. Riedl, M. ClodiLipide und DiabetesJ Kardiol 2002; 9:317-320

40) B. Ludvik, K. Thomaseth, J. Nolan, M. Clodi, R. Prager, G. PaciniInverse relation between amylin and glucagon secretion in healthy and diabetic subjects, Europ. J. of Clin. Invest. 2003;33:316-322

41) Koller MD, Templ E, Riedl M, M. Clodi, Wagner O, Smolen JS, Luger A.Pituitary function in patients with newly diagnosed untreated systemic lupus erythematosus.Ann Rheum Dis. 2004 Dec;63(12):1677-80. Epub 2004 Apr 13.

42) Maier C, Riedl M, M. Clodi, Bieglmayer C, Mlynarik V, Trattnig S, Luger A.Dynamic contrast-enhanced MR imaging of the stimulated pituitary gland.Neuroimage. 2004 May;22(1):347-52.

43) Biesenbach G, Auinger M, M. Clodi, Prischl F, Kramar R; Diabetic Nephropathy Study Group of the Austrian Society of Nephrology. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria. Nephrol Dial Transplant. 2005 Mar;20(3):559-65.

44) Ch. Bieglmayer, M. Clodi, S. KudlacekBiomarker in der Osteologie: Aktueller StandJournal für Mineralstoffwechsel 2006, S 12-16

45) GM. Wieselthaler, M. Riedl, H. Schima, O. Wagner, W. Waldhäusl, E. Wolner, A. Luger, M. Clodi.Endocrine Function is not impaired in Patients With a Continuous MicroMed-DeBakey Axial Flow PumpJ Card Thor Surg 2007 Jan;133(1):2-6

46) M. Clodi, G. Locker, K. Lenz: Therapievorenthalt und Therapiereduktion bei invasiven Maßnahmen und künstlicher Ernährung bei schwerstkranken Patienten.Imago hominis, Band 13 – Heft 4 – 2006

47) C. Maier, M. Riedl, G. Vila, P. Nowotny, M. Wolzt, M. Clodi, B. Ludvik, A.LugerCholinergic regulation of ghrelin and peptide YY release may be impaired in obesity.Diabetes. 2008 Sep;57(9):2332-40. Epub 2008 Jun 20

48) G. Vila, C. Maier, M. Riedl, P. Nowotny, B. Ludvik, A. Luger, M. ClodiBacterial endotoxin induces biphasic changes in plasma ghrelin in healthy humansJ Clin Endocrinol Metab. 2007 Oct;92(10):3930-4

49) M. Clodi, M. Resl, D. Stelzeneder, G. Pacini, A. Tura, D. Mörtl, J.Struck, N.G. Morgentahler, A.Bergmann , M. Riedl, M. Stadler, A. Luger, R. Pacher, M. HülsmannInteractions of glucose metabolism and chronic heart failureExp Clin Endocrinol Diabetes. 2008 Sep 30]


(C) 2010 - Alle Rechte vorbehalten

Diese Seite drucken